Potential applications of the chemiluminescent methods in tumoral diseases investigation

International Journal of Pharma and Bio Sciences

Volumn 2, Issue 2, 2011, Pages 392-400

  Araujo Filho J L S ^a   Melo Junior, M R ^a   Carvalho, L B ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Acridinium ester; Antibody; Chemiluminescence; Tumoral diseases

Indexed keywords

ACRIDINE DERIVATIVE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; HORSERADISH PEROXIDASE; LUMINOL; PROSTATE SPECIFIC ANTIGEN; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; CARCINOMATOSIS; CHEMILUMINESCENCE ENZYME IMMUNOASSAY; CHEMILUMINESCENCE IMMUNOASSAY; CHEMOLUMINESCENCE; DISEASE MARKER; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIVER CELL CARCINOMA; NEOPLASM; NONHUMAN; PROCESS DEVELOPMENT; PROSTATE TUMOR; PROTEIN BLOOD LEVEL; RAMAN SPECTROMETRY; REVIEW; SENSITIVITY AND SPECIFICITY; THYROID TUMOR; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

EID: 84855473597     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Carlson R, Lewis SW, Lim KF, Seeing the light: using chemiluminescence to demonstrate chemical fundamentals. Aust J Chem Educ, 14: 51-53, (2000).
2. Xiao Q, Li H, Lin JM, Development of a highly sensitive magnetic particle-based chemiluminescence enzyme immunoassay for thyroid stimulating hormone and comparison with two other immunoassays. Clinica Chimica Acta, 411: 1151-1153, (2010).
3. Wilson R, Akhavan-Tafti H, DeSilva R, Schaap AP, Comparison Between Acridan Ester, Luminol, and Ruthenium Chelate Electrochemiluminescence. Electroanalysis, 13 (13); 1083-1092, (2001).
4. King, DW, Flow Injection Analysis of H2O2 in Natural Waters Using Acridinium Ester Chemiluminescence: Method Development and Optimization Using a Kinetic Model. Anal Chem, 79: 4169-4176, (2007).
5. Ram S, Siar CH, Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg, 34: 521-527, (2005).
6. Roda A, Guardiglia M, Pasinia P, Mirasolia M, Michelinia E, Musiani M, Bioand chemiluminescence imaging in analytical chemistry. Analytica Chimica Acta, 541: 25-26, (2005).
7. Mann W, Lonky N, Nassad S, Scott R, Blanco J, Vasileu S, Papanicolau smear screening augmented by a magnified chemiluminescent exam. Int J Gynecol Obstet, 43: 289-296, (1993).
8. Lin J, Ju H, Eletrochemical and chemiluminescent immunosensors for tumor markers. Biosens Bioelectron, 20: 1461-1470, (2005).
9. Yang M, Liu C, Hu X, He P, Fang Y, Electrochemiluminescence assay for the detection of acridinium esters. Analytica Chimica Acta, 461 (1): 141-146, (2002).
10. Campos LM, Cavalcanti CBL, Lima-Filho JL, Carvalho-Junior LB, Beltrão EI, Acridinium ester conjugated to lectin as chemiluminescent histochemistry marker. Biomarkers, 11 (5): 480-484, (2003).
11. Ferreira EC, Rossi AV, A Quimiluminescência como ferramenta analítica: do mecanismo a aplicações da reação do luminol em métodos de análise. Química Nova, 25 (6): 1003-1011, (2002).
12. Kricka LJ, Clinical applications of chemiluminescence. Analytica Chimica Acta, 500: 279-386, (2003).
13. Roda A, Pasini P, Musiani M, Baraldini M, Guardigli M, Mirasoli M, Bioanalytical applications of chemiluminescent imaging. Baeyens W GarcÍa-Campaña AM eds. Chemiluminescence in analytical chemistry. Marcel Dekker New York, 473-495, (2002).
14. Yang Z, Fu Z, Yan F, Liu H, Huangxian Ju, A chemiluminescent immunosensor based on antibody immobilized carboxylic resin beads coupled with micro-bubble accelerated immunoreaction for fast flow-injection immunoassay. Biosensors and Bioelectronics, 24: 35-40, (2008).
15. Campbell AK, Hallet MB, Weeks I, Chemiluminescence as na analytical tool in cell biology and medicine. Methods in Biochemical Analysis, 31: 317-416, (1985).
16. Wei HB, Lin JM, Wu DN, Zhao LX, Ji Z, Ying XT, Detection of 17β-Estradiol in River Water and Human Urine by Highly Sensitive Chemiluminescence Enzyme Immunoassay. Chinese Journal of Analytical Chemistry. 35(3): 319-324, (2007).
17. Zhao L, Sun L, Chu X, Chemiluminescence immunoassay. Trends in Analytical Chemistry, 28 (4): 404-415, (2009).
18. Terrier N, Bonardet A, Descomps B, Cristol JP, Dupuy AM, Determination of beta2-microglobulin in biological samples using an immunoenzymometric assay (chemiluminescence detection) or an immunoturbidimetric assay: comparison with a radioimmunoassay. Clinical laboratory, 50 (11-12): 675-683, (2004).
19. Roda A, Pasini P, Guardigli M, Baraldini M, Musiani M, Mirasoli M, Bio- and chemiluminescence in bioanalysis. Fresenius J Anal Chem, 366: 752-759, (2002).
20. Lu S, Song J, Campbell-Palmer L, A modified chemiluminescence method for hydrogen peroxide determination in apple fruit tissues. Scientia Horticulturae, 120: 336-341, (2009).
21. Seitz WR, Immunoassay labels based on chemiluminescence and bioluminescence. Clin Biochem, 17: 120-125, (1984).
22. Lee JH, Rhoa JERR, Rhoa THD, Newby JG, Advent of innovative chemiluminescent enzyme immunoassay. Biosensors and Bioelectronics, 26: 377-382, (2010).
23. Scorilas A, Agiamarnioti K, Papadopoulos K, Novel Biotinylated Acridinium Derivatives: New Reagents for Fluorescence Immunoassays and Proteomics. Clin Chim Acta, 357: 159-167, (2005).
24. Zheng Y, Chen H, Liu XP, Jiang JH, Luo Y, Shen GL, Yu RQ, An ultrasensitive chemiluminescence immunosensor for PSA based on the enzyme encapsulated liposome. Talanta, 77: 809-814, (2008).
25. Schilsky RL, Taube SE, Introduction: Tumor markers as clinical cancer tests are we there yet?. Semin Oncol, 29: 211-2 (2002).
26. Borrebaeck CA, Rouge P, Mitogenic properties of structurally related Lathyrus lectins. Archives of Biochemistry and Biophysics, 248: 30-34, (1986).
27. Soling A, Rainov NG, Bioluminescence imaging in vivo application to cancer research. Expert Opin Biol Ther, 3: 1163-1172, (2003).
28. Yu YA, Timiryasova T, Zhang Q, Beltz R, Szalay AA, Optical imaging: bacteria, viruses, and mammalian cells encoding light-emitting proteins reveal the locations of primary tumors and metastases in animals. Anal Bioanal Chem, 377: 964-972, (2003).
29. Zhuang J, Huang JL, Chen GN, Synthesis of a new biacridine and its use as the chemiluminescent probe for immunoassay of carcinoembryonic antigen, Anal Chim Acta, 512: 347-353, (2004)
30. Wang X, Zhang QY, Li ZJ, Ying XT, Lin JM, Development of high-performance magnetic chemiluminescence enzyme immunoassay for α-fetoprotein (AFP) in human serum. Clinica Chimica Acta, 393 (2): 90-94, (2008).
31. Zhang Q, Wang X, Li Z, Lin JM, Evaluation of α-fetoprotein (AFP) in human serum by chemiluminescence enzyme immunoassay with magnetic particles and coated tubes as solid phases. Analytica Chimica Acta, 631 (2): 212-217, (2009).
32. Koteish A, Thuluvath PJ, Screening for hepatocellular carcinoma. J Vasc Interv Radiol, 13: S185-190, (2002).
33. Zhou L, Liu J, Luo F, Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol, 12: 1175-81, (2006).
34. INCA - Instituto Nacional de Câncer Brasil. Ministério da Saúde. Secretaria de Atenção à Saúde. Coordenação de Prevenção e Vigilância. Estimativa 2010-2011: Incidência de câncer no Brasil. Rio de Janeiro: INCA, (2010).
35. Acevedo B, Perera Y, Ruiz M, Rojas G, Benitez J, Ayala M, Gavilondo J, Development and validation of a quantitative ELISA for the measurement of PSA concentration. Clin Chim Acta, 317: 55-63, (2002).
36. Soukka T, Paukkunen J, Härmä H, Lönnberg S, Lindroos H, Lövgren T, Supersensitive Time-resolved Immunofluorometric Assay of Free Prostate-specific Antigen with Nanoparticle Label Technology. Clinical Chemistry, 47: 1269-1278, (2001).
37. Fang Y, Bjorn P, Stefan L, Wolfgang K, Attomolar sensitivity in bioassays based on surface plasmon fluorescence spectroscopy. J Am Chem Soc, 126 (29): 8902-8903, (2004).
38. Seto Y, Iba T, Abe K, Development of ultrahigh sensitivity bioluminescent enzyme immunoassay for prostate-specific antigen (PSA) using firefly luciferase Luminescence, 16 (4): 285-290, (2001)
39. Fernandez-Sanchez C, McNeil CJ, Rawson K, Nilsson O, Disposable Noncompetitive Immunosensor for Free and Total Prostate-Specific Antigen Based on Capacitance Measurement. Anal Chem, 76: 5649-5656, (2004).
40. Grubisha DS, Lipert RJ, Park HY, Driskell J, Porter MD, Femtomolar detection of prostate-specific antigen: an immunoassay based on surfaceenhanced Raman scattering and immunogold labels. Anal Chem, 75 (21): 5936-5943, (2003).
41. Roberts MA, Kelley SO, Ultrasensitive Detection of Enzymatic Activity with Nanowire electrodes. J Am Chem Soc, 129: 11356-11357, (2007).
42. Nam JM, Thaxton CS, Mirkin CA, Nanoparticles-based bio-bar codes for the ultrasensitive detection of proteins. Science, 301: 1884-1886, (2003).
43. Wu J, Fu Z, Yan F, Huangxian J, Biomedical and clinical applications of immunoassays and immunosensors for tumor markers. Trends in Analytical Chemistry, 26 (7): 679-688, (2007).
44. Chouhan RS, Babu KV, Kumar MA, Neeta NS, Thakur MS, Amitha Rani BE, Pasha A, Karanth GK, Karanth NG, Detection of methyl parathion using immunochemiluminescence based image analysis using charge coupled device. Biosens. Bioelectron, 21: 1264-1271, (2006).
45. Hu D, Han H, Zhou R, Dong F, Bei W, Jia F, Chen H, Gold(III) enhanced chemiluminescence immunoassay for detection of antibody against ApxIV of Actinobacillus pleuropneumoniae. Analyst, 133: 768-773, (2008).
46. Jie GH, Huang X, Sun J, Zhu J, Electrochemiluminescence of CdSe quantum dots for immunosensing of humanprealbumin. Biosens Bioelectron, 23 (12): 1896-1899, (2008).
47. Gupta S, Huda S, Kilpatrick PK, Velev OD, Characterization and optimization of gold nanoparticle-based silver-enhanced immunoassays. Anal Chem, 23: 5498-5504, (2007).